Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1433, 2013-01, pp. : 22-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab: Paradoxical worsening of multiple sclerosis?: case report
Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. :
Access to resources
Recommend
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
Natalizumab: First report of reactivation of herpesvirus infection: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1179, 2007-01 ,pp. :
Natalizumab: Mycobacteriosis: case report
Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. :
Natalizumab knocks out multiple sclerosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. :